Molecular biology and genetics of Alzheimer's disease

被引:135
作者
St George-Hyslop, PH [1 ]
Petit, A [1 ]
机构
[1] Univ Toronto, Toronto Hosp, Dept Med, Div Nephrol, Toronto, ON M5S 3H2, Canada
关键词
Alzheimer's diseased; amyloid precursor protein; presenilin; apolipoprotein E; Tau; genetics;
D O I
10.1016/j.crvi.2004.10.013
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Like several other adult onset neurodegenerative diseases, Alzheimer's disease is a multifactorial illness with both genetic and non-genetic causes. Recent genetic studies have identified four genes associated with inherited risk for AD (presenilin 1, presenilin 2, amyloid precursor protein, and apolipoprotein E). These genes account for about half of the total genetic risk for Alzheimer's disease. It is suspected that several other Alzheimer's disease-susceptibility genes exist, and their identification is the subject of ongoing research. Nevertheless, biological studies on the effects of mutations in the four known genes has led to the conclusion that all of these genes cause dysregulation of amyloid precursor protein processing and in particular dysregulation of the handling of a proteolytic derivative termed Abeta. The accumulation of Abeta appears to be an early and initiating event that triggers a series of downstream processes including misprocessing of the tau protein. This cascade ultimately causes neuronal dysfunction and death, and leads to the clinical and pathological features of Alzheimer's disease. Knowledge of this biochemical cascade now provides several potential targets for the development of diagnostics and therapeutics. (C) 2004 Academie des sciences. Published by Elsevier SAS. All rights reserved.
引用
收藏
页码:119 / 130
页数:12
相关论文
共 90 条
[81]   The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum [J].
Walter, J ;
Capell, A ;
Grunberg, J ;
Pesold, B ;
Schindzielorz, A ;
Prior, R ;
Podlisny, MB ;
Fraser, P ;
Hyslop, PS ;
Selkoe, DJ ;
Haass, C .
MOLECULAR MEDICINE, 1996, 2 (06) :673-691
[82]   Presenilin and γ-secretase:: structure meets function [J].
Wolfe, MS .
JOURNAL OF NEUROCHEMISTRY, 2001, 76 (06) :1615-1620
[83]   Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity [J].
Wolfe, MS ;
Xia, WM ;
Ostaszewski, BL ;
Diehl, TS ;
Kimberly, WT ;
Selkoe, DJ .
NATURE, 1999, 398 (6727) :513-517
[84]   Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors [J].
Wolozin, B ;
Kellman, W ;
Ruosseau, P ;
Celesia, GG ;
Siegel, G .
ARCHIVES OF NEUROLOGY, 2000, 57 (10) :1439-1443
[85]  
Wong P. C., 1996, Society for Neuroscience Abstracts, V22, P728
[86]   NEUROTROPHIC AND NEUROTOXIC EFFECTS OF AMYLOID BETA-PROTEIN - REVERSAL BY TACHYKININ NEUROPEPTIDES [J].
YANKNER, BA ;
DUFFY, LK ;
KIRSCHNER, DA .
SCIENCE, 1990, 250 (4978) :279-282
[87]   Reduced neprilysin in high plaque areas of Alzheimer brain:: a possible relationship to deficient degradation of β-amyloid peptide [J].
Yasojima, K ;
Akiyama, H ;
McGeer, EG ;
McGeer, PL .
NEUROSCIENCE LETTERS, 2001, 297 (02) :97-100
[88]   Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants [J].
Ye, YH ;
Lukinova, N ;
Fortini, ME .
NATURE, 1999, 398 (6727) :525-529
[89]   Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and βAPP processing [J].
Yu, G ;
Nishimura, M ;
Arawaka, S ;
Levitan, D ;
Zhang, LL ;
Tandon, A ;
Song, YQ ;
Rogaeva, E ;
Chen, FS ;
Kawaral, T ;
Supala, A ;
Levesque, L ;
Yu, H ;
Yang, DS ;
Holmes, E ;
Millman, P ;
Liang, Y ;
Zhang, DM ;
Xu, DH ;
Sato, C ;
Rogaev, E ;
Smith, M ;
Janus, C ;
Zhang, YN ;
Aebersold, R ;
Farrer, L ;
Sorbi, S ;
Bruni, A ;
Fraser, P ;
St George-Hyslop, P .
NATURE, 2000, 407 (6800) :48-54
[90]   Mice deficient for the amyloid precursor protein gene [J].
Zheng, H ;
Jiang, M ;
Trumbauer, ME ;
Hopkins, R ;
Sirinathsinghji, DJS ;
Stevens, KA ;
Conner, MW ;
Slunt, HH ;
Sisodia, SS ;
Chen, HY ;
VanderPloeg, LHT .
NEUROBIOLOGY OF ALZHEIMER'S DISEASE, 1996, 777 :421-426